Novan, Inc.

Novan, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Tradey thinks it is not wise to invest in Novan, Inc..
Log in to see more information.
Novan, Inc. is a biotechnology company which uses nitric oxide-based technology to develop product c...

News

Novan CEO Paula Brown Stafford details bankruptcy decision
Novan CEO Paula Brown Stafford details bankruptcy decision

Banking News-Bizjournals.com The longtime Triangle executive reveals what finally pushed Novan into bankruptcy - and what lessons she'll take away from the experience.\n more…

Novan (NASDAQ:NOVN) Stock Crosses Below Fifty Day Moving Average of $0.74
Novan (NASDAQ:NOVN) Stock Crosses Below Fifty Day Moving Average of $0.74

Ticker Report Shares of Novan, Inc. (NASDAQ:NOVN Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.74 and traded as low as $0.12. Novan shares last traded at $0.14, with a volume of 2,917,671 shares. Analysts Set New Price ...\n more…

Why Are Novan Shares Nosediving Today?
Why Are Novan Shares Nosediving Today?

Yahoo! Finance: News Novan Inc (NASDAQ: NOVN) shares are trading lower after Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it has offered to acquire the company's assets. The deal value includes $15 million in cash and provides up to $15 million in DIP financing to Novan, including a $3 million bridge loan already funded.\n more…

Novan craters as company files for bankruptcy, to sell most of its assets
Novan craters as company files for bankruptcy, to sell most of its assets

Seeking Alpha - Healthcare Novan (NOVN) shares plummeted -68.7% on Monday after the company said it had filed for bankruptcy and entered into a deal to sell most of its assets to Ligand Pharmaceuticals (LGND) for...\n more…

Why Are Novan Shares Nosediving Today?
Why Are Novan Shares Nosediving Today?

Benzinga Novan Inc (NASDAQ: NOVN) shares are trading lower after Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it has offered to\n more…

Ligand Offers $15 Million to Acquire Assets of Novan, Inc.
Ligand Offers $15 Million to Acquire Assets of Novan, Inc.

Business Wire Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it has made an offer to acquire the assets of Novan, Inc. (Nasdaq: NOVN) (Novan) for $15 million in cash and provide up to $15...\n more…